Wang Yan, Cui Yanru, Li Xin, Jin Su-Han, Wang Haitao, Gaipl Udo S, Ma Hu, Wang Shixiang, Zhou Jian-Guo
Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, China.
Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.
BMC Med. 2025 Aug 15;23(1):477. doi: 10.1186/s12916-025-04306-5.
Circular RNAs (circRNAs) are emerging as promising tools in cancer and immunotherapy, with unique characteristics that offer potential therapeutic applications.
This review outlines the discovery, biogenesis, and mechanisms of circRNAs, emphasizing their roles in cancer and immune regulation. CircRNAs modulate immune responses by acting as miRNA sponges, binding RNA-binding proteins, or serving as translation templates. These interactions influence T cells, NK cells, macrophages, and immune checkpoints. The review also explores circRNAs' roles in different cancers, focusing on target identification, immune effects, and mechanisms of action. Additionally, it examines circRNA-based therapies, including vaccines, CAR-T cell therapy, and database applications.
Despite their potential, technical hurdles must be overcome to advance circRNAs' clinical use in cancer immunotherapy. Future research should focus on addressing these challenges to fully realize the therapeutic potential of circRNAs.
环状RNA(circRNAs)正成为癌症和免疫治疗中有前景的工具,具有独特特性,提供了潜在的治疗应用。
本综述概述了circRNAs的发现、生物合成及其机制,强调了它们在癌症和免疫调节中的作用。CircRNAs通过充当微小RNA(miRNA)海绵、结合RNA结合蛋白或作为翻译模板来调节免疫反应。这些相互作用影响T细胞、自然杀伤(NK)细胞、巨噬细胞和免疫检查点。该综述还探讨了circRNAs在不同癌症中的作用,重点关注靶点识别、免疫效应和作用机制。此外,还研究了基于circRNA的疗法,包括疫苗、嵌合抗原受体(CAR)-T细胞疗法和数据库应用。
尽管circRNAs具有潜力,但要推进其在癌症免疫治疗中的临床应用,必须克服技术障碍。未来的研究应专注于应对这些挑战,以充分实现circRNAs的治疗潜力。